Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high-grade B-cell lymphoma
Gareau, A., Sekiguchi, T., Warry, E., Ripoll, A. Z., Sullivan, E., Westfall, T., … Suter, S. E. (2022, July 26). VETERINARY AND COMPARATIVE ONCOLOGY.
By: A. Gareau n, T. Sekiguchi n, E. Warry n, A. Ripoll n, E. Sullivan*, T. Westfall *, J. Chretin*, L. Fulton ..., M. Harkey*, R. Storb * & S. Suter n
author keywords: comparative oncology; hematology; oncology; small animal; stem cells
MeSH headings : Dogs; Animals; Humans; Transplantation, Homologous / veterinary; Retrospective Studies; Dog Diseases / surgery; Neoplasm Recurrence, Local / veterinary; Hematopoietic Stem Cell Transplantation / veterinary; Hematopoietic Stem Cell Transplantation / methods; Lymphoma, B-Cell / surgery; Lymphoma, B-Cell / veterinary
TL;DR:
It is suggested that allogeneic HCT can cure ~50% more dogs than those treated with autologous HCT.
(via
Semantic Scholar)
UN Sustainable Development Goal Categories